Clinical Trials Directory

Trials / Completed

CompletedNCT02120872

Platelet Rich Fibrin Combined With Simvastatin for Treatment of Intrabony Defect in Chronic Periodontitis

Platelet - Rich Fibrin Combined With 1.2mg Simvastatin for the Treatment of 3 - Wall Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Government Dental College and Research Institute, Bangalore · Academic / Other
Sex
All
Age
25 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of the present study was to investigate the efficacy of autologous Platelet rich fibrin (PRF) or PRF and Simvastatin (SMV) with open flap debridement (OFD) in the treatment of three wall intrabony defects in comparison to OFD alone.

Detailed description

90 systemically healthy subjects were divided randomly into three groups (30 subjects in each group, per subject one site). Control group consisted of the sites treated with OFD and test groups sites were treated with OFD with autologous PRF or PRF with SMV. Site-specific plaque index (PI), sulcus bleeding index (mSBI), probing depth (PD), relative attachment level (RAL) and intrabony defect (IBD) depth reduction was measured at baseline and 9 month after surgery.

Conditions

Interventions

TypeNameDescription
DRUGPlatelet rich fibrin and simvastatinThree wall intrabony defect sites treated with Open Flap Debridement. 0.1 mL prepared SMV gel (1.2 mg/0.1 mL) was mixed with PRF. The PRF - SMV mixture was delivered to the defect.
BIOLOGICALPlatelet rich fibrinThree wall intrabony defect sites treated with Open Flap Debridement. PRF was placed into the intrabony defect.
PROCEDUREOpen Flap Debridement aloneThree wall intrabony defect sites treated with Open Flap Debridement only. No PRF or SMV was delivered to the defect.

Timeline

Start date
2013-02-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2014-04-23
Last updated
2014-04-23

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02120872. Inclusion in this directory is not an endorsement.